Anti-Tim-3 antibodies and use thereof
US11203637B2 · kind B2 · utility
6Cited by
4References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2017 |
| Grant date | Dec 21, 2021 |
| Priority date | — |
| Expiry date | Oct 14, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are antibodies that specifically bind to T-cell immunoglobulin domain and mucin domain 3 (Tim-3). The anti-Tim-3 antibodies can be used to treat, prevent or diagnose immune, cancerous, infectious diseases or other pathological disorders that may be modulated by Tim-3-mediated functions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.